Stepwise analysis of MIR9 loci identifies miR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patients

[1]  M. Iorio,et al.  miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer. , 2016, Cancer research.

[2]  Y. Zhang,et al.  Nucleation of DNA repair factors by FOXA1 links DNA demethylation to transcriptional pioneering , 2016, Nature Genetics.

[3]  B. Evert,et al.  Reciprocal Regulation between Bifunctional miR-9/9∗ and its Transcriptional Modulator Notch in Human Neural Stem Cell Self-Renewal and Differentiation , 2016, Stem cell reports.

[4]  M. Iorio,et al.  Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts , 2016, Cell Death and Disease.

[5]  Hua Jiang,et al.  Prognostic role of miR-9 expression in various human malignant neoplasms: a meta-analysis , 2016, OncoTargets and therapy.

[6]  Daniel R. Zerbino,et al.  Ensembl 2016 , 2015, Nucleic Acids Res..

[7]  Nicola Valeri,et al.  An evaluation and replication of miRNAs with disease stage and colorectal cancer‐specific mortality , 2015, International journal of cancer.

[8]  H. Baba,et al.  miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells , 2015, British Journal of Cancer.

[9]  M. Behmanesh,et al.  Analyses of methylation status of CpG islands in promoters of miR-9 genes family in human gastric adenocarcinoma , 2015, Molecular biology research communications.

[10]  Denis Thieffry,et al.  RSAT 2015: Regulatory Sequence Analysis Tools , 2015, Nucleic Acids Res..

[11]  A. Luini,et al.  Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy. , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  Xiong Cai,et al.  Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma , 2014, Diagnostic Pathology.

[13]  Shuxia Han,et al.  MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma , 2014, World Journal of Surgical Oncology.

[14]  Jay R. Hesselberth,et al.  HITS-CLIP reveals key regulators of nuclear receptor signaling in breast cancer , 2014, Breast Cancer Research and Treatment.

[15]  M. Copetti,et al.  Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients , 2014, Molecular Cancer.

[16]  John M S Bartlett,et al.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. , 2014, Archives of pathology & laboratory medicine.

[17]  Hao Wu,et al.  Reversing DNA Methylation: Mechanisms, Genomics, and Biological Functions , 2014, Cell.

[18]  F. Aqil,et al.  MicroRNA 'signature' during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention. , 2013, Cancer letters.

[19]  Fedor V. Karginov,et al.  Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates. , 2013, Genes & development.

[20]  J. Parker,et al.  MicroRNA 9-3p Targets β1 Integrin To Sensitize Claudin-Low Breast Cancer Cells to MEK Inhibition , 2013, Molecular and Cellular Biology.

[21]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[22]  ENCODEConsortium,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[23]  Anton J. Enright,et al.  MicroRNA-9 Inhibition of Cell Proliferation and Identification of Novel miR-9 Targets by Transcriptome Profiling in Breast Cancer Cells* , 2012, The Journal of Biological Chemistry.

[24]  Christopher A. Loffredo,et al.  MicroRNA-9 as Potential Biomarker for Breast Cancer Local Recurrence and Tumor Estrogen Receptor Status , 2012, PloS one.

[25]  Peter A. Jones,et al.  A decade of exploring the cancer epigenome — biological and translational implications , 2011, Nature Reviews Cancer.

[26]  O. Abdel-Wahab,et al.  TET family proteins and their role in stem cell differentiation and transformation. , 2011, Cell stem cell.

[27]  Wing-Kin Sung,et al.  Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state , 2011, Molecular systems biology.

[28]  Hiroshi Kiyonari,et al.  MicroRNA-9 Regulates Neurogenesis in Mouse Telencephalon by Targeting Multiple Transcription Factors , 2011, The Journal of Neuroscience.

[29]  T. Sun,et al.  MicroRNA miR-9 Modifies Motor Neuron Columns by a Tuning Regulation of FoxP1 Levels in Developing Spinal Cords , 2011, The Journal of Neuroscience.

[30]  A. Pisco,et al.  MicroRNA-9 Reveals Regional Diversity of Neural Progenitors along the Anterior-Posterior Axis , 2011, Developmental cell.

[31]  J. Gu,et al.  Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinoma , 2010, Oncogene.

[32]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. , 2010, Archives of pathology & laboratory medicine.

[33]  Frank Speleman,et al.  miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis , 2010, Nature Cell Biology.

[34]  Xabier Agirre,et al.  Epigenetic regulation of microRNA expression in colorectal cancer , 2009, International journal of cancer.

[35]  Min Liu,et al.  MicroRNA‐9 inhibits ovarian cancer cell growth through regulation of NF‐κB1 , 2009, The FEBS journal.

[36]  Sandya Liyanarachchi,et al.  Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. , 2009, Cancer research.

[37]  A. Nicholson,et al.  CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma—A miRNA microarray analysis , 2009, Genes, chromosomes & cancer.

[38]  Bo Liu,et al.  Down-regulated miR-9 and miR-433 in human gastric carcinoma , 2009, Journal of experimental & clinical cancer research : CR.

[39]  Mikael Bodén,et al.  MEME Suite: tools for motif discovery and searching , 2009, Nucleic Acids Res..

[40]  S. Ropero,et al.  A microRNA DNA methylation signature for human cancer metastasis , 2008, Proceedings of the National Academy of Sciences.

[41]  Iris Barshack,et al.  MiR‐92b and miR‐9/9* Are Specifically Expressed in Brain Primary Tumors and Can Be Used to Differentiate Primary from Metastatic Brain Tumors , 2008, Brain pathology.

[42]  Stephen P Finn,et al.  Potential role of miR-9 and miR-223 in recurrent ovarian cancer , 2008, Molecular Cancer.

[43]  U. Lehmann,et al.  Epigenetic inactivation of microRNA gene hsa‐mir‐9‐1 in human breast cancer , 2008, The Journal of pathology.

[44]  Stephen W. Wilson,et al.  MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system , 2007, Genome Biology.

[45]  M. Esteller.  Epigenetic gene silencing in cancer: the DNA hypermethylome. , 2007, Human molecular genetics.

[46]  R. Plasterk,et al.  RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain. , 2005, RNA.

[47]  Douglas G Altman,et al.  Reporting recommendations for tumor marker prognostic studies. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  H. Horvitz,et al.  MicroRNA Expression in Zebrafish Embryonic Development , 2005, Science.

[49]  R. Schiff,et al.  Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer. , 2005, Clinical Cancer Research.

[50]  D. Seripa,et al.  Nonrandom Distribution of Aberrant Promoter Methylation of Cancer-Related Genes in Sporadic Breast Tumors , 2004, Clinical Cancer Research.

[51]  Jacques van Helden,et al.  Regulatory Sequence Analysis Tools , 2003, Nucleic Acids Res..

[52]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[53]  J. Soh,et al.  Impact of aberrant methylation of microRNA-9 family members on non-small cell lung cancers. , 2013, Molecular and clinical oncology.

[54]  Wyeth W. Wasserman,et al.  JASPAR: an open-access database for eukaryotic transcription factor binding profiles , 2004, Nucleic Acids Res..

[55]  Terrence S. Furey,et al.  The UCSC Table Browser data retrieval tool , 2004, Nucleic Acids Res..